SCHEMBL5758766

SCHEMBL5758766

COC(=O)N1CCC(C2=CC[CH]C=C2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.40
BRDT Q58F21 1/20 0.40
PDE4B Q07343 3/20 0.37
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 1/20 0.35
EPHX1 P07099 1/20 0.34
CYP3A4 P08684 3/20 0.33
CYP2C19 P33261 2/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
USP2 O75604 2/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL693163 0.85 MAPT (0.50) L3MBTL1MAPTKMT2AALDH1A1EPHX1
SCHEMBL694872 0.84 QDPR (0.43) BRD4MAPTALDH1A1EPHX1KDM4E
SCHEMBL1570148 0.77 BRD4 (0.40) BRD4BRDTPDE4BPDE4APDE4C
SCHEMBL187985 0.75 QDPR (0.35)
SCHEMBL18305577 0.72
SCHEMBL2479279 0.69 SLC18A3 (0.47) KMT2AALDH1A1KDM4E
SCHEMBL6021739 0.69 DRD2 (0.47)
SCHEMBL31073550 0.68 KCNH2 (0.56) BRD4L3MBTL1KMT2AALDH1A1CYP3A4
SCHEMBL18481125 0.68 QDPR (0.45) BRD4KMT2AALDH1A1EPHX1KDM4E
SCHEMBL23865987 0.67 CYP3A4 (0.51) BRD4BRDTALDH1A1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1635824-A2 5-MEMBERED HETEROCYCLE-BASED P-38 INHIBITORS Novartis AG (CH) 2006-03-22 EP claimed
WO-2005000298-A2 5-MEMBERED HETEROCYCLE-BASED P-38 INHIBITORS NOVARTIS AG (CH) 2005-01-06 WO claimed
EP-1635824-A2 5-MEMBERED HETEROCYCLE-BASED P-38 INHIBITORS Novartis AG (CH) 2006-03-22 EP disclosed
WO-2005000298-A2 5-MEMBERED HETEROCYCLE-BASED P-38 INHIBITORS NOVARTIS AG (CH) 2005-01-06 WO disclosed